CONTROL OF FIBROBLAST SENESCENCE AND ACTIVATION OF PROGRAMMED CELL-DEATH

被引:62
|
作者
WANG, E
LEE, MJ
PANDEY, S
机构
[1] MCGILL UNIV,FAC MED,DEPT MED,MONTREAL H3A 2T5,QUEBEC,CANADA
[2] MCGILL UNIV,FAC MED,DEPT ANAT,MONTREAL H3A 2T5,QUEBEC,CANADA
关键词
REPLICATIVE SENESCENCE; CELL-CYCLE TRAVERSE; PROGRAMMED CELL DEATH; APOPTOSIS; ONCOGENES AND ANTIONCOGENES;
D O I
10.1002/jcb.240540410
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have characterized a nuclear phosphoprotein of 57 kda, statin, found only in nonproliferating cells of both quiescent and senescent natures. Emerging results suggest that statin may function as a sequester to block the early G1 phase phosphorylation for the RB protein. A second protein, terminin, undergoes senescence-specific posttranslational modification from 90 to 60 kda, and further death-specific conversion from 60 to 30 kda. We also found that apoptotic mouse 3T3 fibroblasts express c-fos, c-myc, c-jun, and cdc2, as well as the upregulation of RB phosphorylation and BrdU incorporation, just before final DNA fragmentation and death. It seems that en route to death, cells re-enter the cell-cycle traverse and experience early G1 and part of S Phase; however, this cycling event is an abortive one. In contrast, senescent fibroblasts are resistant to the initiation of the death program, since they are unable to enter cell cycle traverse. Long-term serial passaging of normal human fibroblasts may be inadvertently selecting those, while termed as senescent, are also specialized survivors, and thus a good culture model to study both the control of permanent departure from cell cycle traverse and the mechanism underlying the survival or antideath cellular program. (C) 1994 Wiley-Liss, Inc.
引用
收藏
页码:432 / 439
页数:8
相关论文
共 50 条
  • [21] BACTERIA AND PROGRAMMED CELL-DEATH
    ZYCHLINSKY, A
    SANSONETTI, PJ
    RECHERCHE, 1994, 25 (264): : 444 - 445
  • [22] APOPTOSIS OR PROGRAMMED CELL-DEATH
    FELDMANN, G
    ANNALES DE PATHOLOGIE, 1995, 15 (02) : 92 - 109
  • [23] INDUCTION AND ACTIVATION OF TISSUE TRANSGLUTAMINASE DURING PROGRAMMED CELL-DEATH
    FESUS, L
    THOMAZY, V
    FALUS, A
    FEBS LETTERS, 1987, 224 (01) : 104 - 108
  • [24] PROGRAMMED CELL-DEATH IN DICTYOSTELIUM
    CORNILLON, S
    FOA, C
    DAVOUST, J
    BUONAVISTA, N
    GROSS, JD
    GOLSTEIN, P
    JOURNAL OF CELL SCIENCE, 1994, 107 : 2691 - 2704
  • [25] PROGRAMMED CELL-DEATH IN DROSOPHILA
    AGAPITE, J
    GRETHER, M
    LAMBLIN, AF
    WHITE, K
    STELLER, H
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1995, 11 : S78 - S78
  • [26] THE BIOCHEMISTRY OF PROGRAMMED CELL-DEATH
    KROEMER, G
    PETIT, P
    ZAMZAMI, N
    VAYSSIERE, JL
    MIGNOTTE, B
    FASEB JOURNAL, 1995, 9 (13): : 1277 - 1287
  • [27] PROGRAMMED CELL-DEATH OF THE NORMAL HUMAN NEUTROPHIL - AN IN-VITRO MODEL OF SENESCENCE
    PAYNE, CM
    GLASSER, L
    TISCHLER, ME
    WYCKOFF, D
    CROMEY, D
    FIEDERLEIN, R
    BOHNERT, O
    MICROSCOPY RESEARCH AND TECHNIQUE, 1994, 28 (04) : 327 - 344
  • [28] REPLICATIVE SENESCENCE AND CELL-DEATH
    LINSKENS, MHK
    HARLEY, CB
    WEST, MD
    CAMPISI, J
    HAYFLICK, L
    SCIENCE, 1995, 267 (5194) : 17 - 17
  • [29] THE GENES THAT CONTROL PROGRAMMED CELL-DEATH - FROM WORM TO MAMMAL
    YUAN, JY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 209 : 243 - MEDI
  • [30] ACTIVATION OF PROGRAMMED CELL-DEATH BY ANTICANCER AGENTS - CISPLATIN AS A MODEL SYSTEM
    EASTMAN, A
    CANCER CELLS-A MONTHLY REVIEW, 1990, 2 (8-9): : 275 - 280